The ISRC fosters innovation, basic research, technology development, bi-directional community-led activities, training and translational programs to avert the risk of cancer due to exposures from per- and polyfluoroalkyl substances (PFAS). We adopt a system-based approach to understand fate and transport, develop mitigation strategies, and create novel treatment technologies to degrade PFAS to minimize pollution and improve public health. Our cancer-focused center also identifies mechanisms to understand PFAS-induced carcinogenesis to suggest biomarkers and therapeutic targets that can empower community-led public health cancer risk reduction, prevention and intervention decisions and actions. Learn more.

For Questions and Inquiries Please Contact Dr. Tor Jensen (ISRC Administration Lead) or Dr. Joseph Irudayaraj (ISRC Director)